MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss and
comprehensive loss
-$4,591K
(92.80%↑ Y/Y)
Therapeutics
$4,369K
(6.72%↑ Y/Y)
Diagnostics
$799K
(98.26%↑ Y/Y)
Development Services
$302K
Therapeutics
$1,433K
(-20.39%↓ Y/Y)
Development Services
$374K
Diagnostics
$167K
(7.05%↑ Y/Y)
Revenue From Contract
With Customer...
$1,244K
Development Services
$92K
Therapeutics
$19K
(-59.57%↓ Y/Y)
Net loss
-$4,534K
(92.89%↑ Y/Y)
Unrealized loss, change in
fair value of...
-$43K
(-138.89%↓ Y/Y)
Change in foreign
currency translation
-$14K
(-122.58%↓ Y/Y)
Consumables Revenue
$5,470K
(21.64%↑ Y/Y)
Capital Revenue
$1,974K
(0.92%↑ Y/Y)
Engineering Revenue
$1,244K
Product And Service
Other
$111K
(136.17%↑ Y/Y)
Loss before income
taxes
-$4,495K
(92.96%↑ Y/Y)
Income tax expense
(benefit)
$39K
(168.42%↑ Y/Y)
Interest income
$455K
(-37.67%↓ Y/Y)
Net revenue
$8,799K
(35.37%↑ Y/Y)
Loss from operations
-$4,900K
(92.41%↑ Y/Y)
Gross profit
$5,484K
(24.44%↑ Y/Y)
Other expense
-$26K
(40.91%↑ Y/Y)
Loss on disposal of
assets
-$15K
(-87.50%↓ Y/Y)
Foreign exchange (loss)
income
-$9K
(-325.00%↓ Y/Y)
Cost of revenue
$3,315K
(58.39%↑ Y/Y)
General and
administrative
$5,413K
(-13.56%↓ Y/Y)
Selling and marketing
$3,817K
(-23.77%↓ Y/Y)
Research and development
$1,154K
(-37.72%↓ Y/Y)
Back
Back
Income Statement
Zomedica Corp. (ZOMDF)
Zomedica Corp. (ZOMDF)
source: myfinsight.com